1987
DOI: 10.1016/s0735-1097(87)80234-6
|View full text |Cite
|
Sign up to set email alerts
|

Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy

Abstract: In acute myocardial infarction, myocardial salvage is dependent on rapid restoration of blood flow. Pharmacologic (streptokinase, recombinant tissue-type plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty, guide wire perforation) or combined forms of reperfusion therapy can accomplish this goal, but their effects on infarcted myocardium and vessel occlusion site have not been compared at necropsy. The heart of 19 necropsy patients who had received various forms of acute reperfus… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0

Year Published

1990
1990
2009
2009

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 148 publications
(26 citation statements)
references
References 43 publications
1
24
0
Order By: Relevance
“…21,25,26 Myocardial edema, contraction band necrosis, and intramyocardial hemorrhage are commonly noted at autopsy in elderly hearts after fibrinolysis. 27 In 706 elderly STEMI patients (Ն75 years of age), free wall rupture occurred in 17.1% treated with fibrinolytic therapy versus 4.9% who received PCI and 7.9% who received no reperfusion. 20 Fibrinolytic therapy may have unique adverse myocardial effects in those of advanced age.…”
Section: Discussionmentioning
confidence: 99%
“…21,25,26 Myocardial edema, contraction band necrosis, and intramyocardial hemorrhage are commonly noted at autopsy in elderly hearts after fibrinolysis. 27 In 706 elderly STEMI patients (Ն75 years of age), free wall rupture occurred in 17.1% treated with fibrinolytic therapy versus 4.9% who received PCI and 7.9% who received no reperfusion. 20 Fibrinolytic therapy may have unique adverse myocardial effects in those of advanced age.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast with the early phase, mortality and myocardial salvage are influenced by time-independent (or 'less dependent') effects of reperfusion therapy, collateral circulation, ischemic preconditioning and myocardial oxygen demand (41,48). Moreover, reperfusion therapy may be associated with adverse effects such as contraction band necrosis (caused by rapid influx of calcium into dying cells), reperfusion injury, intramural hemorrhage, iatrogenic coronary artery dissection and distal microvascular embolization (49,50). Administering fibrinolytic therapy less than 2 h after symptom onset, more readily accomplished in the prehospital setting, halts myocardial injury at the reversible stages.…”
Section: Timing Of Fibrinolysis and Subsequent Pcimentioning
confidence: 99%
“…22,23 By treating the underlying fissured plaque, primary PCI also reduces recurrent ischemia and reinfarction compared with both fibrin-specific and -nonspecific agents. 13 Moreover, reperfusion injury and hemorrhagic transformation of a bland infarction, which occurs after fibrinolytic therapy but rarely after primary PCI, 24,25 also may result in increased myonecrosis and the mechanical complications of transmural infarction. 26 Finally, despite exclusion of patients at high risk for major bleeding and neurological events in the randomized comparative trials, log-rank p for trend = 0.0003 2.8% Figure 2.…”
Section: Primary Pci In Stemi Comparison With Fibrinolytic Therapymentioning
confidence: 99%